BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2544289)

  • 21. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kinetics of 14C-GR43175 in rat and dog.
    Dallas FA; Dixon CM; McCulloch RJ; Saynor DA
    Cephalalgia; 1989; 9 Suppl 9():53-6. PubMed ID: 2544284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumatriptan in acute migraine: pharmacology and review of world experience.
    Peroutka SJ
    Headache; 1990; 30 Suppl 2():554-60. PubMed ID: 2177047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sumatriptan in the treatment of migraine.
    Ferrari MD
    Neurology; 1993 Jun; 43(6 Suppl 3):S43-7. PubMed ID: 8389011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sumatriptan--future development, alternative features and potential new indications].
    Arnold WS
    Neurol Neurochir Pol; 1992; Suppl 2():49-56. PubMed ID: 1337767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sumatriptan.
    Bateman DN
    Lancet; 1993 Jan; 341(8839):221-4. PubMed ID: 8093509
    [No Abstract]   [Full Text] [Related]  

  • 27. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A
    Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan: a new serotonin agonist for the treatment of migraine headache.
    Susman JL
    Am Fam Physician; 1993 Feb; 47(3):645-7. PubMed ID: 8382004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous sumatriptan in acute migraine.
    JAMA; 1991 Nov; 266(19):2703-4. PubMed ID: 1658406
    [No Abstract]   [Full Text] [Related]  

  • 30. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group.
    Ekbom K; Monstad I; Prusinski A; Cole JA; Pilgrim AJ; Noronha D
    Acta Neurol Scand; 1993 Jul; 88(1):63-9. PubMed ID: 8396833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.
    Caekebeke JF; Ferrari MD; Zwetsloot CP; Jansen J; Saxena PR
    Neurology; 1992 Aug; 42(8):1522-6. PubMed ID: 1322512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Headache recurrence after subcutaneous sumatriptan.
    Dahlöf C
    Lancet; 1992 Feb; 339(8790):425-6. PubMed ID: 1346679
    [No Abstract]   [Full Text] [Related]  

  • 34. Sumatriptan in the treatment of acute migraine with aura.
    Banerjee M; Findley LJ
    Cephalalgia; 1992 Feb; 12(1):39-44. PubMed ID: 1313746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and tolerability of sumatriptan: an overview.
    Brown EG; Endersby CA; Smith RN; Talbot JC
    Eur Neurol; 1991; 31(5):339-44. PubMed ID: 1653142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sumatriptan: a new drug for vascular headache.
    Hsu VD
    Clin Pharm; 1992 Nov; 11(11):919-29. PubMed ID: 1334452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan.
    Fowler PA; Lacey LF; Thomas M; Keene ON; Tanner RJ; Baber NS
    Eur Neurol; 1991; 31(5):291-4. PubMed ID: 1653135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.
    Goldstein J; Dahlöf CG; Diener HC; Olesen J; Schellens R; Senard JM; Simard D; Steiner TJ
    Cephalalgia; 1996 Nov; 16(7):497-502. PubMed ID: 8933995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.